Schedule 13G ownership disclosure
XILIO THERAPEUTICS INC
Common Stock, par value $0.0001 per share · CUSIP: 98422T100
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Rock Springs Capital Management LP
Shares: 0.00 · Class: 0%
- Rock Springs Capital LLC
Shares: 0.00 · Class: 0%
- Rock Springs Capital Master Fund LP
Shares: 0.00 · Class: 0%
- Mark Bussard
Shares: 0.00 · Class: 0%
- Kris Jenner
Shares: 0.00 · Class: 0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001172661-25-002077
- Form type
- SCHEDULE 13G/A
- Filer
- Rock Springs Capital Management LP
- CIK
- CIK 1595725
- Filed
- May 15, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership